Ronald Dorenbos MSc, PhD

As Head of Innovation Management and Scouting and as a member of Takeda’s Digital Strategy team Ronald helps Takeda with its technology and innovation strategy. Earlier, at the Life Science division of PA Consulting, Ronald led projects for some of the world’s top 10 pharmaceutical companies that included projects around strategy, commercialization, and digital health and at his company BioFrontline he provided management, strategy, and commercial advice to life sciences companies in the US, Europe, and Asia.

After obtaining MAs in Biotechnology and Molecular Biology and a PhD in Pharmaceutical Biology at the University Medical Center Groningen in the Netherlands Ronald spent six years at Harvard studying Parkinson’s, Schizophrenia and the genetics of aggressive behavior, before making the transition to industry. As a consultant, Ronald got involved in projects related to artificial intelligence and he has been following the field over the last 10 years. He is frequently invited to deliver presentations and keynotes related to AI in Pharma and Healthcare and has presented at numerous events internationally. He is also the founder of the LinkedIn groups ‘AI – Artificial Intelligence’, ‘Small Molecules’, ‘Boston Biotech’ and ‘Golden Triangle Biotech’ that serve over 10,000 members.